THE MINISTRY OF HEALTH ________ No. 10/2024/TT-BYT | THE SOCIALIST REPUBLIC OF VIETNAM Independence - Freedom - Happiness ________________________ Hanoi, June 13, 2024 |
CIRCULAR
Promulgating the list of infectious diseases, subjects and scope of obligatory use of vaccines and medical bio-products
________________
Pursuant to the Law on Prevention and Control of Infectious Diseases dated November 21, 2007;
Pursuant to the Government's Decree No. 95/2022/ND-CP dated November 15, 2022, defining the functions, tasks, powers and organizational structure of the Ministry of Health;
At the request of the Director General of the General Department of Preventive Medicine;
The Minister of Health promulgates the list of infectious diseases, subjects and scope of obligatory use of vaccines and medical bio-products.
Article 1. List of infectious diseases, subjects obliged to use vaccines and immunization schedules in the Expanded Program on Immunization
1. List of infectious diseases, subjects obliged to use vaccines and immunization schedules under the Expanded Program on Immunization
No. | Infectious disease | Vaccines, subjects, immunization schedules in the Expanded Program on Immunization |
Vaccine | Subject | Immunization/dosage schedule |
1 | Hepatitis B | Monovalent hepatitis B vaccine | Infants | Birth dose: within 24 hours of birth |
Hepatitis B-containing combination vaccine | Children | Dose 1: at 02 months of age Dose 2: at least 01 month (*) after dose 1 Dose 3: at least 01 month after dose 2 |
2 | Tuberculosis | Bacillus Calmette-Guérin (BCG) vaccine | Children | Administered once within 01 month after birth |
3 | Diphtheria | Diphtheria- containing combination vaccine | Children | Dose 1: at 02 months of age Dose 2: at least 01 month after dose 1 Dose 3: at least 01 month after dose 2 |
Children | Booster dose at 18 months of age |
Reduced diphtheria- containing combination vaccine | Children | Booster dose at 07 years of age |
4 | Pertussis | Pertussis- containing combination vaccine | Children | Dose 1: at 02 months of age Dose 2: at least 01 month after dose 1 Dose 3: at least 01 month after dose 2 |
Children | Booster dose at 18 months of age |
5 | Tetanus | Tetanus-containing combination vaccine | Children | Dose 1: at 02 months of age Dose 2: at least 01 month after dose 1 Dose 3: at least 01 month after dose 2 |
Children | Booster dose at 18 months of age |
Tetanus-containing combination vaccine | Children | Booster dose at 07 years of age |
Tetanus-containing vaccine for pregnant women | Pregnant women | 1. For pregnant women who have never been vaccinated or have not been vaccinated with 3 primary doses of tetanus-containing vaccine (**), or have an unknown history of vaccination: - Dose 1: Early administration during pregnancy; - Dose 2: At least 1 month after dose 1; - Dose 3: During subsequent pregnancy and at least 6 months after dose 2; - Dose 4: During subsequent pregnancy and at least 01 year after dose 3; - Dose 5: During subsequent pregnancy and at least 01 year after dose 4. 2. For pregnant women who have been vaccinated with 3 primary doses of tetanus-containing vaccine: - Dose 1: Early administration during pregnancy; - Dose 2: At least 01 month after dose 1; - Dose 3: During subsequent pregnancy and at least 01 year after dose 2. 3. For pregnant women who have been vaccinated with 3 primary doses of tetanus-containing vaccine and 01 booster dose: - Dose 1: Early administration during pregnancy; - Dose 2: During subsequent pregnancy and at least 01 year after dose 1. 4. For pregnant women who have been vaccinated with 3 primary doses of tetanus-containing vaccine and 2 booster doses: Early administration during pregnancy In all situations, the 2nd dose and subsequent doses should be administered at least 02 weeks before the expected date of birth. |
6 | Poliomyelitis | Oral polio vaccine | Children | Dose 1: at 02 months of age Dose 2: at least 01 month after dose 1 Dose 3: at least 01 month after dose 2 |
Injectable polio vaccine | Children | Dose 1: at 05 months of age Dose 2: at 09 months of age |
7 | Diseases caused by Haemophilus influenzae type b (Hib) | Monovalent Hib-containing vaccine or Hib-containing combination vaccine | Children | Dose 1: at 02 months of age Dose 2: at least 01 month after dose 1 Dose 3: at least 01 month after dose 2 |
8 | Measles | Measles-containing vaccine | Children | administered at 09 months of age |
Measles-containing combination vaccine | Children | administered at 18 months of age |
9 | Japanese B encephalitis | Japanese B encephalitis vaccine | Children | Dose 1: at 01 year of age Dose 2: 1-2 weeks after dose 1 Dose 3: 1 year after dose 1 |
10 | Rubella | Rubella-containing combination vaccine | Children | administered at 18 months of age |
11 | Diarrhoea due to rotavirus | Rota vaccine | Children | Dose 1: taken at 02 months of age Dose 2: taken at least 01 month after dose 1 |
(*) The interval between doses every 1 month is calculated to be at least 28 days.
(**) Primary dose is the dose administered before reaching 1 year of age
2. For those who have not been vaccinated on schedule or have not received full doses, they must be vaccinated as soon as possible but must ensure that they are suitable for the subjects under the guidance of the Ministry of Health and the manufacturer.
3. Immunization under campaign or supplementary immunization shall be carried out under the guidance of the Ministry of Health in each specific case.
Article 2. List of infectious diseases and subjects obliged to use vaccines and medical bio-products for people at risk of contracting infectious diseases in epidemic areas or going to epidemic areas.
1. List of infectious diseases and vaccines and medical bio-products subject to obligatory use:
No. | Infectious disease | Vaccine and medical bio-product |
1 | Diphtheria | Diphtheria- containing combination vaccine and diphtheria antitoxin serum |
2 | Poliomyelitis | Polio vaccine or polio- containing combination vaccine |
3 | Pertussis | Pertussis - containing combination vaccine |
4 | Rubella | Rubella vaccine or rubella- containing combination vaccine |
5 | Measles | Measles vaccine or measles- containing combination vaccine |
6 | Cholera | Cholera vaccine |
7 | Japanese B encephalitis | Japanese B encephalitis vaccine |
8 | Rabies | Rabies vaccine, anti-rabies serum |
9 | Influenza | Influenza vaccine |
10 | COVID-19 | COVID-19 vaccine |
2. The subjects obliged to use vaccines and medical bio-products for people at risk of contracting infectious diseases in epidemic areas or going to epidemic areas in the list specified in Clause 1 of this Article shall be determined by provincial-level Departments of Health and reported to provincial- or municipal-level People's Committees for decision, or determined according to the direction of the Ministry of Health based on the epidemic situation, conditions for supply of vaccines and medical bio-products, and local resources.
Article 3. Scope of obligatory use of vaccines and medical bio-products
1. Vaccines in the list specified in Clause 1, Article 1 of this Circular shall be deployed nationwide for children and pregnant women in the Expanded Program on Immunization.
2. The scope of use of vaccines and medical bio-products in the list specified in Clause 1, Article 2 of this Circular shall be determined by provincial-level Departments of Health and reported to provincial- or municipal-level People's Committees for decision, or determined according to the direction of the Ministry of Health based on the epidemic situation, conditions for supply of vaccines and medical bio-products, and local resources.
Article 4. Effect
1. This Circular takes effect from August 1, 2024.
2. Circular No. 38/2017/TT-BYT dated October 17, 2017 of the Minister of Health promulgating the list of infectious diseases, subjects and scope of obligatory use of vaccines and medical bio-products ceases to be effective from the effective date of this Circular.
Article 5. Implementation responsibilities
The Director General of the General Department of Preventive Medicine, heads of units under the Ministry of Health; Directors of provincial- and municipal-level Departments of Health and relevant agencies, organizations and individuals shall implement this Circular.
Any difficulties or problems arising during the course of implementation shall be promptly reported to the Ministry of Health (the General Department of Preventive Medicine) for consideration and resolution. /.
For the Minister
The Deputy Minister
NGUYEN THI LIEN HUONG
Vietnamese
Circular 10/2024/TT-BYT PDF (Original)
Circular 10/2024/TT-BYT DOC (Word)
